ResearcherGuangdong General HospitalNo recent work listed

Yifan Duan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7900-6541; OpenAlex author ID A5050905842. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells. Co-author DOI 10.1177/1533033819895494 ↗
Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS. Co-author DOI 10.1016/s1499-3872(13)60032-6 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zijun Li · 2 shared papers, 2013–2020 · strength 0.15
- Paper Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells. DOI 10.1177/1533033819895494 ↗
- Paper Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS. DOI 10.1016/s1499-3872(13)60032-6 ↗
Xiaoyu Yin · 1 shared paper, 2020 · strength 0.11
- Paper Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells. DOI 10.1177/1533033819895494 ↗
Zijun Xie · 1 shared paper, 2020 · strength 0.11
- Paper Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells. DOI 10.1177/1533033819895494 ↗
Fan Meng · 1 shared paper, 2020 · strength 0.11
- Paper Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells. DOI 10.1177/1533033819895494 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.